Literature DB >> 34136961

Kappa Opioid Receptor Mediated Differential Regulation of Serotonin and Dopamine Transporters in Mood and Substance Use Disorder.

Durairaj Ragu Varman1, Lankupalle D Jayanthi2, Sammanda Ramamoorthy3.   

Abstract

Dynorphin (DYN) is an endogenous neurosecretory peptide which exerts its activity by binding to the family of G protein-coupled receptors, namely the kappa opioid receptor (KOR). Opioids are associated with pain, analgesia, and drug abuse, which play a central role in mood disorders with monoamine neurotransmitter interactions. Growing evidence demonstrates the cellular signaling cascades linked to KOR-mediated monoamine transporters regulation in cell models and native brain tissues. This chapter will review DYN/KOR role in mood and addiction in relevance to dopaminergic and serotonergic neurotransmissions. Also, we discuss the recent findings on KOR-mediated differential regulation of serotonin and dopamine transporters (SERT and DAT). These findings led to a better understanding of the role of DYN/KOR system in aminergic neurotransmission via its modulatory effect on both amine release and clearance. Detailed knowledge of these processes at the molecular level enables designing novel pharmacological reagents to target transporter motifs to treat mood and addiction and reduce unwanted side effects such as aversion, dysphoria, sedation, and psychomimesis.
© 2021. The Author(s), under exclusive license to Springer Nature Switzerland AG.

Entities:  

Keywords:  Addiction; Dopamine transporter; Dynorphin; Kappa opioid receptor; Mood; Serotonin transporter; Signaling

Mesh:

Substances:

Year:  2022        PMID: 34136961     DOI: 10.1007/164_2021_499

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  104 in total

Review 1.  Current treatments of the anxiety disorders in adults.

Authors:  J C Ballenger
Journal:  Biol Psychiatry       Date:  1999-12-01       Impact factor: 13.382

2.  Presynaptic opioid receptors on noradrenergic and serotonergic neurons in the human as compared to the rat neocortex.

Authors:  Benjamin Berger; Anna Katharina Rothmaier; Franziska Wedekind; Josef Zentner; Thomas J Feuerstein; Rolf Jackisch
Journal:  Br J Pharmacol       Date:  2006-06-05       Impact factor: 8.739

3.  The kappa-opioid receptor is primarily postsynaptic: combined immunohistochemical localization of the receptor and endogenous opioids.

Authors:  U Arvidsson; M Riedl; S Chakrabarti; L Vulchanova; J H Lee; A H Nakano; X Lin; H H Loh; P Y Law; M W Wessendorf
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

4.  Mitogenic signaling via endogenous kappa-opioid receptors in C6 glioma cells: evidence for the involvement of protein kinase C and the mitogen-activated protein kinase signaling cascade.

Authors:  L M Bohn; M M Belcheva; C J Coscia
Journal:  J Neurochem       Date:  2000-02       Impact factor: 5.372

Review 5.  Kinase-dependent Regulation of Monoamine Neurotransmitter Transporters.

Authors:  Daniel P Bermingham; Randy D Blakely
Journal:  Pharmacol Rev       Date:  2016-10       Impact factor: 25.468

6.  Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine ("Ecstasy") in serotonin transporter-deficient mice.

Authors:  D Bengel; D L Murphy; A M Andrews; C H Wichems; D Feltner; A Heils; R Mössner; H Westphal; K P Lesch
Journal:  Mol Pharmacol       Date:  1998-04       Impact factor: 4.436

7.  Chemogenetic Manipulation of Dopamine Neurons Dictates Cocaine Potency at Distal Dopamine Transporters.

Authors:  Zachary D Brodnik; Wei Xu; Aashita Batra; Stacia I Lewandowski; Christina M Ruiz; Ole V Mortensen; Sandhya Kortagere; Stephen V Mahler; Rodrigo A España
Journal:  J Neurosci       Date:  2020-10-12       Impact factor: 6.167

8.  Seeking (and Finding) Biased Ligands of the Kappa Opioid Receptor.

Authors:  Laura M Bohn; Jeffrey Aubé
Journal:  ACS Med Chem Lett       Date:  2017-07-05       Impact factor: 4.345

Review 9.  Targeting opioid dysregulation in depression for the development of novel therapeutics.

Authors:  Caroline A Browne; Irwin Lucki
Journal:  Pharmacol Ther       Date:  2019-04-30       Impact factor: 12.310

10.  CRF1-R activation of the dynorphin/kappa opioid system in the mouse basolateral amygdala mediates anxiety-like behavior.

Authors:  Michael R Bruchas; Benjamin B Land; Julia C Lemos; Charles Chavkin
Journal:  PLoS One       Date:  2009-12-31       Impact factor: 3.240

View more
  1 in total

Review 1.  The role of enkephalinergic systems in substance use disorders.

Authors:  Lauren G Rysztak; Emily M Jutkiewicz
Journal:  Front Syst Neurosci       Date:  2022-08-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.